G1 Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon. My name is Jason Russell. I'm member of the Morgan Stanley Healthcare Investment Banking team. And I'm excited to be here this afternoon to speak with the G1 team. We're joined by G1's CEO, Mark Velleca; as well as G1's Chief Commercial Officer, Soma Gupta.
It's an incredibly exciting time for G1 with the potential for the company's first NDA approval coming in early 2021. So I'm looking forward to today's discussion, Mark and Soma.
Maybe before I jump in, a quick disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect to reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
